Shelton LM - Search Results

1

Is the restricted ketogenic diet a viable alternative to the standard of care for managing malignant brain cancer?

Seyfried TN, Marsh J, Shelton LM, Huysentruyt LC, Mukherjee P. Seyfried TN, et al. Among authors: shelton lm. Epilepsy Res. 2012 Jul;100(3):310-26. doi: 10.1016/j.eplepsyres.2011.06.017. Epub 2011 Aug 31. Epilepsy Res. 2012. PMID: 21885251 Review.

2

Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?

Seyfried TN, Shelton L, Arismendi-Morillo G, Kalamian M, Elsakka A, Maroon J, Mukherjee P. Seyfried TN, et al. Neurochem Res. 2019 Oct;44(10):2392-2404. doi: 10.1007/s11064-019-02795-4. Epub 2019 Apr 25. Neurochem Res. 2019. PMID: 31025151

3

Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model.

Shelton LM, Huysentruyt LC, Seyfried TN. Shelton LM, et al. Int J Cancer. 2010 Nov 15;127(10):2478-85. doi: 10.1002/ijc.25431. Int J Cancer. 2010. PMID: 20473919 Free PMC article.

4

Calorie restriction as an anti-invasive therapy for malignant brain cancer in the VM mouse.

Shelton LM, Huysentruyt LC, Mukherjee P, Seyfried TN. Shelton LM, et al. ASN Neuro. 2010 Jul 23;2(3):e00038. doi: 10.1042/AN20100002. ASN Neuro. 2010. PMID: 20664705 Free PMC article.

5

Metabolic management of brain cancer.

Seyfried TN, Kiebish MA, Marsh J, Shelton LM, Huysentruyt LC, Mukherjee P. Seyfried TN, et al. Among authors: shelton lm. Biochim Biophys Acta. 2011 Jun;1807(6):577-94. doi: 10.1016/j.bbabio.2010.08.009. Epub 2010 Sep 8. Biochim Biophys Acta. 2011. PMID: 20804725 Free article. Review.

6

Thematic review series: sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a.

Mukherjee P, Faber AC, Shelton LM, Baek RC, Chiles TC, Seyfried TN. Mukherjee P, et al. Among authors: shelton lm. J Lipid Res. 2008 May;49(5):929-38. doi: 10.1194/jlr.R800006-JLR200. Epub 2008 Feb 20. J Lipid Res. 2008. PMID: 18287616 Free PMC article.

7

Metastatic cancer cells with macrophage properties: evidence from a new murine tumor model.

Huysentruyt LC, Mukherjee P, Banerjee D, Shelton LM, Seyfried TN. Huysentruyt LC, et al. Among authors: shelton lm. Int J Cancer. 2008 Jul 1;123(1):73-84. doi: 10.1002/ijc.23492. Int J Cancer. 2008. PMID: 18398829 Free article.

8

Influence of methotrexate and cisplatin on tumor progression and survival in the VM mouse model of systemic metastatic cancer.

Huysentruyt LC, Shelton LM, Seyfried TN. Huysentruyt LC, et al. Among authors: shelton lm. Int J Cancer. 2010 Jan 1;126(1):65-72. doi: 10.1002/ijc.24649. Int J Cancer. 2010. PMID: 19536778 Free article.

9

A novel pre-clinical in vivo mouse model for malignant brain tumor growth and invasion.

Shelton LM, Mukherjee P, Huysentruyt LC, Urits I, Rosenberg JA, Seyfried TN. Shelton LM, et al. J Neurooncol. 2010 Sep;99(2):165-76. doi: 10.1007/s11060-010-0115-y. Epub 2010 Jan 13. J Neurooncol. 2010. PMID: 20069342

10

Cancer as a metabolic disease.

Seyfried TN, Shelton LM. Seyfried TN, et al. Among authors: shelton lm. Nutr Metab (Lond). 2010 Jan 27;7:7. doi: 10.1186/1743-7075-7-7. Nutr Metab (Lond). 2010. PMID: 20181022 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page